Apollomics

Apollomics

Apollomics

Apollomics is an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies.
Founded
2016
Raised
$100M
Follow us
Alexa global traffic share
Twitter followers
08 Jan 2019
$100,000,000
Venture capital (Series B)

Apollomics racks up $100 mln Series B

PE HUB
+1